Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning for Stem Cell Transplantation.

被引：0
|
作者：
Bremer, S. [1 ]
Floeisand, Y. [2 ]
Bergan, S. [3 ,4 ]
机构：
[1] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway
[2] Oslo Univ Hosp, Dept Hematol, Oslo, Norway
[3] Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway
[4] Univ Oslo, Sch Pharm, Oslo, Norway
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-03003
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A30
引用
收藏
页码：880 / 880
页数：1
相关论文
共 50 条
  • [11] Non myeloablative conditioning does not prevent telomere attrition after stem cell transplantation.
    Lahav, M
    Nagler, A
    Shapiro, C
    Kastenbaum, M
    Szyper-Kravitz, M
    Radnay, J
    Uziel, O
    BLOOD, 2002, 100 (11) : 213A - 213A
  • [12] Safety and Efficacy of Outpatient Myeloablative Busulfan Conditioning in Allogeneic Stem Cell Transplantation
    Cliburn, John
    Kubli, Kara
    Feeney, Tate
    Blaney, Margaret
    Zhang, Victoria
    Aljitawi, Omar
    Liesveld, Jane L.
    Becker, Michael W.
    Huselton, Eric J.
    BLOOD, 2023, 142
  • [13] Influence of Glutathione S-Transferase A1 and P1 Polymorphisms on the Outcome of Hematopoietic Stem Cell Transplantation with Busulfan Based Conditioning Regimen In Children
    Lee, Ji Won
    Kang, Hyoung Jin
    Yuk, Yen Ju
    Jang, Mi Kyoung
    Han, Eun Jong
    Kim, Nam Hee
    Kim, Hyery
    Park, Kyung Duk
    Shin, Hee Young
    Ahn, Hyo Seop
    BLOOD, 2010, 116 (21) : 1435 - 1435
  • [14] Influence of Fludarabine on the Pharmacokinetics of Oral Busulfan During Pretransplant Conditioning for Hematopoietic Stem Cell Transplantation
    de Castro, Francine Attie
    Lanchote, Vera Lucia
    Voltarelli, Julio Cesar
    Rensi Colturato, Virgilio Antonio
    Simoes, Belinda Pinto
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1205 - 1211
  • [15] Influence Of GST Gene Polymorphisms On Busulfan Pharmacokinetics and Outcome Of Hematopoietic Stem Cell Transplantation In Thalassemia Pediatric Patients
    Ansari, Marc
    Resgui, Aziz
    Huezo-Diaz, Patricia
    Marktel, Sarah
    Duval, Michel
    Bittencourt, Henrique
    Cappelli, Barbara
    Krajinovic, Maja
    BLOOD, 2013, 122 (21)
  • [16] Influence of Glutathione S-Transferase (GST) Gene Polymorphisms On the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation.
    Kim, Sung-Doo
    Lee, Je-Hwan
    Ryu, Seong-Gil
    Hur, Eun-Hye
    Kang, Mun Jung
    Lee, Jung-Hee
    Kim, Dae-Young
    Lim, Sung-Nam
    Lee, Young-Shin
    Kang, Young-Ah
    Lim, Hyeong-Seok
    Bae, Kyun Seop
    Noh, Gyu Jeong
    Yun, Sung-Cheol
    Han, Sang Beom
    Lee, Kyoo-Hyung
    BLOOD, 2009, 114 (22) : 484 - 485
  • [17] Pharmacokinetics of mycophenolate mofetil after blood stem cell transplantation.: Impact of conditioning therapy
    Jenke, A
    Renner, U
    Freiberg-Richter, J
    Röllig, C
    Babatz, J
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S183 - S183
  • [18] Costs of complications after allogeneic myeloablative stem cell transplantation.
    Saito, Akiko M.
    Cutler, Corey
    Zahrieh, David
    Ho, Vincent T.
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Lee, Stephanie J.
    BLOOD, 2006, 108 (11) : 844A - 844A
  • [19] Immune recovery after non myeloablative stem cell transplantation.
    Larosa, F
    Deconinck, E
    de Tailly, PD
    Tiberghien, P
    Saas, P
    Cahn, JY
    BLOOD, 2002, 100 (11) : 435B - 436B
  • [20] Non-myeloablative conditioning is associated with reduced pro-inflammatory cytokine storm compared to myeloablative conditioning after allogeneic stem cell transplantation.
    Tzolas, AC
    Devidas, M
    Mina, S
    Cartwright, B
    Salansky, J
    Wingard, JR
    Reddy, V
    BLOOD, 2001, 98 (11) : 186A - 186A
12345